Tg Therapeutics (TGTX) Stock Price, Quote & News

Company Profile

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The com...

Industry: Biotechnology

Sector: Healthcare

Phone: 212 554 4484

Fax: 212 554 4531

Website: www.tgtherapeutics.com

Address:

3020 Carrington Mill Blvd., Suite 475, Morrisville, United States

retire2029 Aug. 19 at 4:06 PM

$TGTX SP looks like tempting you to sell shares ASAP. No way now.

0 · Reply

Lions1_83 Aug. 19 at 3:09 PM

$TGTX Nice day so far Let's continue the climb 💰GLTA

1 · Reply

Superdave737 Aug. 19 at 2:57 PM

$TGTX We’re going ballistic. Hang on longs and enjoy the ride. Can’t wait till mid 2027.

0 · Reply

CedarPark Aug. 19 at 2:41 PM

$TGTX Aug $55 Calls expire 2 days from now but are seeing some action, 176 contracts so far. :)

0 · Reply

stu Aug. 19 at 2:41 PM

$TGTX "TG Therapeutics (NASDAQ:TGTX) Combines Strong Growth with a Breakout Setup". Posted by zipjet on X. https://www.chartmill.com/news/TGTX/Chartmill-53765-TG-Therapeutics-NASDAQTGTX-Combines-Strong-Growth-with-a-Breakout-Setup

1 · Reply